Clinical implications of p53 mutations

Cell Mol Life Sci. 1999 Jan;55(1):64-75. doi: 10.1007/s000180050270.


The ultimate goal of basic cancer research is to provide a theoretical foundation for rational approaches to improve cancer therapy. Our extensive insight into the biology of the p53 tumour suppressor and the clinical behaviour of tumours harbouring p53 mutations indicates that information concerning p53 will be useful in diagnosis and prognosis, and may ultimately produce new therapeutic strategies. At the same time, efforts to understand the clinical implications of p53 mutations have revealed conceptual and technical limitations in translating basic biology to the clinic. The lessons learned from p53 may lay the groundwork for future efforts to synthesize cancer gene function, cancer genetics and cancer therapy.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antineoplastic Agents / toxicity
  • Apoptosis / genetics
  • Cell Cycle / genetics
  • Drug Resistance / genetics
  • Genes, Tumor Suppressor / genetics
  • Genes, p53 / genetics*
  • Humans
  • Mutation / genetics*
  • Neoplasms / diagnosis
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • Protein Binding / genetics


  • Antineoplastic Agents